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Abstract A new potent serotonin 5-HT2A receptor agonist
was identified in blotter papers by several state level
forensic laboratories in Brazil. The 25I-NBOH is a labile
molecule, which fragments into 2C-I when analyzed by
routine seized material screening gas chromatography
(GC) methods. GC–mass spectrometry (MS), liquid chro-
matography–quadrupole time-of-flight-MS, and Fourier
transform infrared and nuclear magnetic resonance analy-
ses were performed to complete molecular characteriza-
tion. Individual doses range from 300 to 1000 lg. Despite
its being a potent 5-HT2A receptor agonist, 25I-NBOH is
neither registered in the United Nations Office on Drugs
and Crime (UNODC) nor classified as a scheduled sub-
stance in most countries. Sweden and Brazil seem to be the
only countries to control 25I-NBOH. To our knowledge,
this is the first scientific report dealing with identification
of 25I-NBOH in actual seizures.
Keywords 25I-NBOH  NBOH  Phenethylamine
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Introduction
The global market for new psychoactive substances (NPSs)
continues to expand, and seizures have increased 18%
since 2014 [1]. The number of different drugs available is a
striking feature of this market. Just in 2015, 75 new sub-
stances were reported [2]. Phenethylamines have a
stable presence in the drug market, being reported every
year since its first report in 2008. Many reported
phenethylamines are actually derivatives of previously
reported substances such as the series of 2,5-dimethoxy
ring-substituted phenethylamines (2C series) [1].
Starting from 2014, shortly after NBOMes were pro-
hibited in Brazil, forensic laboratories around the country
started to receive blotter papers and detected the presence
of 2C-I by gas chromatography–mass spectrometry (GC–
MS), which was considered as a golden standard for this
type of sample. Quantification analyses, however, demon-
strated that drug concentrations present in these samples
were much below the minimal dosage reported to be able to
produce any biological effect in the human body. This fact
instigated a more detailed analysis of the samples by liquid
chromatography–quadrupole time-of-flight-mass spec-
trometry (LC–QTOF-MS), which led us to identify 25I-
NBOH (2-({[2-(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}
methyl)phenol) as the real compound present in the analyzed
samples (Fig. 1). To complete structural characterization of
this compound, collaboration with other forensic laboratories
was established, and nuclear magnetic resonance (NMR) and
Fourier transform infrared (FTIR) analyses were also carried
out [3].
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The NBOH compounds are N-benzylhydroxy derivatives
of the 2C hallucinogen family often containing a halogen
group (i.e., chlorine, bromine, or iodine) at position 4 of theA
ring and a hydroxyl group in the position 20 in the B ring. The
NBOH compounds are proposed as a legal alternative for the
NBOMe compounds, even if their physiological and toxi-
cological properties are not fully reported. The N-benzyl,
more specifically N-(2-methoxy)benzyl phenethylamine
substituents, dramatically improved both binding affinity
and functional activity, resulting in vivo 5-HT2A activation.
These compounds including 25I-NBOH are truly selective,
high affinity, potent, and highly efficacious agonists of the
human 5HT2A receptor, responsible for subjective and
behavioral effects [4].
Scientific data regarding NBOH compounds are very
scarce. Only a few pharmacological studies on mice or
computational models have been conducted on these drugs
[4–10]. Only a single paper reported the recovery of 25C-
NBOH, together with 25C-NBOMe and 2C-C from urine
samples in three adult males, one of whom died experi-
encing respiratory difficulties. Internally, the autopsy
showed mild to moderate coronary atherosclerosis,
biventricular dilatation, mild right ventricular hypertrophy
and bilateral pulmonary edema and congestion [11].
Materials and methods
Chemical and reagents
Methanol with 0.1% formic acid CHROMASOLV for
high-performance liquid chromatography (HPLC),
C99.9%, and water with 0.1% formic acid
CHROMASOLV for HPLC, were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Methanol, the LC–MS
grade, C99.9%, was purchased from Scharlau (Barcelona,
Spain). Deuterated chloroform (CDCl3) with 99.8% iso-
topic purity, containing 0.03% (v/v) tetramethylsilane
(TMS), was obtained from Sigma-Aldrich. A certified
reference standard of 25I-NBOH was purchased from
Cayman Chemical, Ann Arbor, MI, USA. A 2C-I certified
reference standard was kindly donated by the United
Nations Office on Drugs and Crime (UNODC).
Samples
Blotter papers suspected to contain illicit substances were
seized between 2014 and 2016 by police forces from the
Federal District, Goia´s State and Minas Gerais State. These
blotters usually represented a colorful side including
drawings of famous celebrities, cartoon characters, fruits,
etc. (Fig. 2) and a white side. Sometimes on the white side
a chemical structure is displayed.
Fig. 1 Chemical structures of 2C-I and 25I-NBOH
Fig. 2 Blotter papers
containing illicit substances
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Instruments
GC–MS analyses were performed using a combined Agi-
lent 7890A gas chromatograph and 5975C mass spec-
trometer (Agilent Technologies, Santa Clara, CA, USA).
The system was controlled with Agilent Chemstation GC/
MS Software version E 02.02.1431. LC–TOF-MS analysis
was performed with an Agilent 6540 QTOF mass spec-
trometer equipped with a Jet Stream interface for electro-
spray ionization (ESI), with an Agilent 1290 Infinity LC
instrument. Compounds were detected and reported from
accurate mass scan data using an Agilent MassHunter
Qualitative Analysis B 06.00 and Personal Compound
Database and Library (PCDL) B 02.00 software, and the
quantitative analysis was performed using an Agilent
MassHunter Quantitative B 07.01. All NMR data were
acquired at 25 C using a Bruker Avance III 500 spec-
trometer (Bruker, Karlsruhe, Germany) operated at 11.75 T
(1H resonance frequency 500.13 MHz), equipped with a
5 mm triple resonance broadband. All acquisition and
processing were conducted by TopSpin software (Version
3.2 Bruker BioSpin).
Attenuated total reflectance (ATR)-FTIR spectra were
taken using a NicoletTM iZ10 spectrometer equipped with
an EverGlo IR source, DLaTGS room temperature infrared
(IR) detector and single-bounce Smart OrbitTM accessory
module with a diamond ATR crystal. All hardware was
purchased from Thermo Fischer Scientific Inc. (Waltham,
MA, USA).
Methods
For GC–MS and LC–QTOF-MS analyses, extraction of
blotter paper samples was carried out with no pretreatment
at room temperature as follows. One blotter was placed in a
test tube, and 10 mL of methanol was added followed by
sonication in an ultrasound bath for 10 min. Ten micro-
liters of this solution was then added to a vial containing
1 mL of methanol, and GC–MS and/or LC–QTOF-MS
analyses were performed.
The GC was equipped with an Agilent J&W DB-1 ms
fused-silica capillary GC column (30 m 9 0.25 mm i.d.,
0.25 lm film thickness). The sample injection volume was
0.5 lL at a split ratio of 50:1. Helium was used as a carrier
gas at 1 mL/min. The inlet line temperature was set at
280 C, and the injector temperature was maintained at
200 C. The GC oven temperature program started with an
initial temperature of 100 C and initial hold time of 0 min.
Then temperature increased to 300 C at a rate of 6 C/
min. The maximum temperature was held for 5.67 min. An
electron ionization source was utilized with a mass ana-
lyzer operating in full scan mode (m/z 34–600).
The LC–QTOF-MS method was performed as follows.
For internal mass calibration, two reference masses were
infused to perform mass correction in every scan:
121.050873 (purine) and 922.009798 (HP-0921) in positive
ionization mode. Mobile phase A consisted of 0.1% formic
acid in water, and the mobile phase B consisted of 0.1%
formic acid in methanol. Separation was performed with a
Zorbax Eclipse Plus C18 (100 9 2.1 mm i.d., particle size
1.8 lm) column (Agilent Technologies). Injection volume
was 1 lL. The instrument acquired data using the follow-
ing parameters: drying gas temperature, 350 C; drying gas
flow, 8.0 L/min; nebulizer, 35 psi; sheath gas temperature,
400 C; sheath gas flow, 11 L/min; VCap, 3500 V; nozzle,
0 V; skimmer, 65 V; and octopole RF peak, 750 V.
The ATR-FTIR spectra were collected directly from
blotter papers. Two spectra were collected from each
blotter, one at the back side, which normally presented no
artwork, and one at the front side, where the main artwork
was located.
Each spectrum were averaged over 16 scans, taken at
4 cm-1 resolution; maximum detector window aperture
and minimum interferometer mirror speed were set in the
range of 400–4000 cm-1. Background signal was averaged
over eight scans prior to each measurement.
For NMR analysis, five blotters were placed in a 2 mL
vial and 600 lL of deuterated chloroform (CDCl3) was
added followed by sonication in an ultrasound bath for
5 min. NMR spectra were recorded using a zg sequence.
One hundred twenty-eight (128) free induction decays
(FIDs) were collected into 64 k data points using a 9.49 ls
pulse width (90 pulse angle), spectral width of 10,000 Hz,
relaxation delay of 1.0 s and an acquisition time of 3.28 s.
The phase and baseline were automatically corrected. An
exponential weighing factor corresponding to line broad-
ening of 0.3 Hz was applied to the FIDs. The heteronuclear
single quantum coherence (HSQC) and heteronuclear
multiple-bond correlation (HMBC) experiments were
Fig. 3 Cleavage of 25I-NBOH using different fragmentor voltages.
Percent relative volume = percentage of 2C-I and 25I-NBOH in
relation to the sum of both peaks in the same retention time
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acquired with spectral windows of 10,000 and
37,731.109 Hz for 1H and 13C, respectively.
Results and discussion
The GC–MS analysis of blotter papers seized by several
state level forensic laboratories in Brazil indicated the
presence of 2C-I. Retention time (RT) and fragmentation
patterns were confirmed with the 2C-I standard. Quantifi-
cation analysis demonstrated an average of 2 mg/mL in
each sample. The known doses for 2C-I that have any
hallucinogen effect in human body are above 14 mg [12],
which led us to perform further analysis.
Preliminary LC–QTOF-MS analysis using fragmentor
voltage at 110 V in the scan mode showed a total ion
current chromatogram of the target compound with a peak
at 8.519 min. However, the ESI mass spectrum showed
two exact mass fragments: m/z 308.0142 [M ? H]? (2C-I)
and m/z 414.0561 [M ? H]?. A search in our PCDL
(Agilent Technologies) was carried out and suggested that
the ion at m/z 414.0561, compatible with the molecular
formula of C17H20INO3, represented the compound 2-({[2-
(4-iodo-2,5-dimethoxyphenyl)ethyl]amino}methyl) phenol
(25I-NBOH). The error between the observed and theo-
retical mass number of [M ? H]? was less than 2 ppm.
Therefore, analytical characterization of this new com-
pound was necessary.
The collision induced dissociation (CID) was carried out
in order to identify the precursor ion [M ? H]? present in
the analyzed sample. Considering that at higher fragmentor
voltage settings, fragmentation can be initiated in the
region between the end of the transfer capillary and the first
skimmer cone, high-resolution mass data was acquired
using different fragmentor voltages (50–260 V). Low
Fig. 4 Product ion spectrum of 25I-NBOH showing the corresponding chemical structure at 80 and 20 V of fragmentor voltage and collision
energy, respectively, obtained by liquid chromatography–quadrupole time-of-flight-tandem mass spectrometry
Fig. 5 Total ion current chromatogram (TIC) for 25I-NBOH and 2C-I showing the same retention time by gas chromatography–mass
spectrometry analyses
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Fig. 6 Spectral comparison showing infrared (IR) profiles obtained
from the backside of a sample blotter and reference standard spectra.
Arrow shows the decrease indicating the substitution of OCH3 by OH
in the 25I-NBOH. a Spectral profile from the back side of a blotter
containing 25I-NBOH. b IR spectrum of 25I-NBOMe (from
SWGDRUG IR library). c IR spectrum from 2C-I (from SWGDRUG
IR library)
Fig. 7 1H nuclear magnetic resonance spectra of blotter paper showing the presence of the substance 25I-NBOH
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energy spectra predominantly showed the m/z 414.0561
(25I-NBOH) ion. The relative intensity of the ions at m/z
414.0561 and 308.0142 present an inverse relation. For
fragmentor voltages up to 110 V, no m/z 308.0142 (2C-I)
ion was present. This result indicates that the 2C-I ion
previously observed was resulting from 25I-NBOH frag-
mentation (Fig. 3).
Subsequently, the CID analysis was carried out with
fixed fragmentor voltage (80 V) and different collision
energies (10, 20 and 40 V). The CID spectrum observed at
20 V of collision energy presented the protonated molecule
[M ? H]? at m/z 414.0561 (11), m/z 107.0491 (69), m/z
308.0142 (40) and m/z 290.9876 (100) (Fig. 4). The ions
detected at m/z 107.0491 and 308.0142 are produced by the
cleavage of the C–N bond corresponding to o-cresol and
2C-I, respectively. The ion recorded at m/z 290.9876 is
formed after the loss of the amine from the 2C-I fragment
[9], and it corresponds to the most abundant ion in the CID
spectrum of 25I-NBOH. The presented results suggest that
2C-I (m/z 308.0142) is a fragment of the 25I-NBOH,
explaining the presence of this compound in the high-en-
ergy production spectra of this drug.
GC–MS analyses of the 25I-NBOH reference standard
presented the same retention time and fragmentation into
2C-I, being indistinguishable by this technique (Fig. 5).
This fact associated with the LC–QTOF-MS results pre-
sents fundamental evidence of the instability of the 25I-
NBOH to be degraded into 2C-I by the usual high tem-
perature in the CG–MS injector or even with the routine
fragmentor voltage by LC–QTOF-MS.
ATR-FTIR spectra of the seized blotters were analyzed
employing both single and multicomponent IR spectral
profile analyses [13] identifying signals matching primarily
25I-NBOMe (SWGDRUG infrared library). Comparative
spectrum analyses between the results obtained from
blotter papers and references standards for 25I-NBOME
and 2C-I were performed, because GC–MS analyses pre-
sented a positive result for 2C-I. Interpretation of the ATR-
FTIR spectra indicated that, despite the higher degree of
similarity with 25I-NBOMe than with 2C-I, a systematic
decrease of the spectral band centered around 1250 cm-1,
characteristic of asymmetric C–O–C vibrations of NBOMe
compounds, was observed. The decrease of this peak
indicates the substitution of OCH3 by OH in the NBOH
structure, resulting in an NBOH compound (Fig. 6).
The 1H spectrum by NMR spectroscopy obtained for
blotter papers is shown in Fig. 7. The multiplicities, cou-
pling constants (J) and chemical shifts (d) are attributed to
one 1,2,4,5-tetrasubstituted aromatic ring containing two
methoxy, one iodine and one ethylmethylamine groups.
Attached to this amine group was observed one 1,2-dis-
ubstituted aromatic ring that also contained one hydroxyl
group.
HSQC and HMBC experiments were used to confirm the
carbon skeleton connectivity. These experiments were also
used for complete carbon chemical shift assignments. The
strong shielding observed for the ipso-carbon (C-4; d 82.9)
confirmed the iodine presence attached directly to aromatic
ring. On the other hand, the deshielding of C-20 (d 158.2)
corroborated the presence of a hydroxyl group substituent.
Table 1 1H and 13C nuclear
magnetic resonance spectral
data for 25I-NBOH (500 MHz,
CDCl3)
Position d1Ha d13C 2J 3J
1 – 128.5 – –
2 – 152.2 – –
3 7.22 (1H, s) 121.7 C-2, C-4 C-1
4 – 82.9 – –
5 – 152.5 – –
6 6.65 (1H, s) 113.6 C-5, C-1 C-4, C-7
7 2.83 (2H, t, J = 7.0 Hz) 30.6 C-8, C-1 C-2, C-6
8 2.92 (2H, t, J = 7.0 Hz) 48.0 C-7 C-10, C-1
10 3.98 (2H, s) 52.2 C-10 C-8, C-20, C-60
10 – 122.0 – –
20 – 158.2 – –
30 6.84 (1H, dd, J = 8.13, 1.07 Hz) 116.3 C-20 C-10, C-50
40 7.16 (1H, ddd, J = 8.13, 7.50, 1.70 Hz) 128.7 – C-20, C-60
50 6.77 (1H, ddd, J = 7.50, 7.50, 1.07 Hz) 118.9 C-60 C-10, C-30
60 6.97 (1H, dd, J = 7.50, 1.70 Hz) 128.2 – C-10, C-20, C-40
OCH3-2 3.75 (s) 56.0 – C-2
OCH3-5 3.81 (s) 57.0 – C-5
a The multiplicity patterns are abbreviated as singlet (s), triplet (t), double doublet (dd) and double double
doublet (ddd)
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The complete 1H and 13C signals assignment and the cor-
relations 1H-13C are presented in Table 1.
Conclusions
In recent years, new psychoactive substances have rapidly
emerged in drug markets, purportedly as ‘‘legal’’ alterna-
tives to internationally controlled drugs. The correct iden-
tification of an NPS is a challenge from an analytical point
of view due to new drugs being produced with only slight
chemical modifications to the existing structures. In this
study, we found a new phenethylamine derivative from the
NBOMe compounds in blotter papers seized in three dif-
ferent Brazilian states. Accurate LC–QTOF-MS and ATR-
FTIR and NMR analyses enabled us to identify this com-
pound as 25I-NBOH.
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